This week, South Africa announced it would halt the rollout of 1 million doses of the Oxford-AstraZeneca vaccine after results from a recent study showed the vaccine wasn’t effective against mild and moderate cases of a local COVID-19 variant. Now, the country is having to reevaluate its vaccine rollout strategy. The World’s Halima Gikandi reports.
We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!